Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap.
Jonker AH, Tataru EA, Graessner H, Dimmock D, Jaffe A, Baynam G, Davies J, Mitkus S, Iliach O, Horgan R, Augustine EF, Bateman-House A, Pasmooij AMG, Yu T, Synofzik M, Douville J, Lapteva L, Brooks PJ, O'Connor D, Aartsma-Rus A; N-of-1 Task Force of the International Rare Diseases Research Consortium (IRDiRC). Jonker AH, et al. Among authors: pasmooij amg. Nat Rev Drug Discov. 2025 Jan;24(1):40-56. doi: 10.1038/s41573-024-01059-3. Epub 2024 Nov 4. Nat Rev Drug Discov. 2025. PMID: 39496921 Review.
Drug repurposing for rare: progress and opportunities for the rare disease community.
Jonker AH, O'Connor D, Cavaller-Bellaubi M, Fetro C, Gogou M, 't Hoen PAC, de Kort M, Stone H, Valentine N, Pasmooij AMG. Jonker AH, et al. Among authors: pasmooij amg. Front Med (Lausanne). 2024 Jan 17;11:1352803. doi: 10.3389/fmed.2024.1352803. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38298814 Free PMC article.
The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies.
Beaverson KL, Julkowska D, Letinturier MCV, Aartsma-Rus A, Austin J, Bueren J, Frost S, Hamamura M, Larkindale J, LaRosa G, Magenheim R, Merico A, Pasmooij AMG, Pirard V, Ekow Thomford N, Wada M, Wong-Rieger D, Hartman AL. Beaverson KL, et al. Among authors: pasmooij amg. Ther Adv Rare Dis. 2023 Jul 29;4:26330040231188979. doi: 10.1177/26330040231188979. eCollection 2023 Jan-Dec. Ther Adv Rare Dis. 2023. PMID: 37529076 Free PMC article.
Report of the European Medicines Agency Conference on RNA-Based Medicines.
Ehmann F, Kuhn A, Pasmooij AMG, Humphreys A, Van Hengel A, Dooley B, Anliker B, Svensson C, Capaldi D, Henshall D, Cooke E, Zhou H, Bastaerts H, Smink J, Van Gerven J, Enes L, Nechev L, Hoefnagel M, Driessens M, Wenger M, Blanquie O, Widomski P, Herold R, Thürmer R, Ruiz S, Thirstrup S, Goody S, Zaks T, Cordò V, Aartsma-Rus AM. Ehmann F, et al. Among authors: pasmooij amg. Nucleic Acid Ther. 2024 Feb;34(1):4-11. doi: 10.1089/nat.2023.0021. Epub 2024 Jan 4. Nucleic Acid Ther. 2024. PMID: 38174996
Revising EU pharmaceutical legislation: will it foster drug repurposing?
Scholte M, Grimm SE, Pauly B, Verbeeck F, Pasmooij AMG, Bouma B, van Duijn-Wiersma J, Guney E, Kesselheim AS, Schmidt HHHW, Joore MA. Scholte M, et al. Among authors: pasmooij amg. Drug Discov Today. 2025 Jan 3:104286. doi: 10.1016/j.drudis.2024.104286. Online ahead of print. Drug Discov Today. 2025. PMID: 39756647 Free article.
89 results